Imago BioSciences Inc

8-K

Completion of Acquisition or Disposition of Assets, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Material Modification to Rights of Security Holders, Change of Control, Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

01/11/23

8-K

Presents Positive Data From Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2022

12/12/22

8-K

Form of Tender and Support Agreement

11/21/22

8-K

Reports Third Quarter 2022 Financial Results and Provides Recent Business Updates

11/09/22

8-K

Change in Directors, Officers or Compensation

09/01/22

8-K

##### ####### ######### ########## ## ########

08/18/22

8-K

####### ###### ####### #### ######### ####### ### ######## ###### ######## #######

08/12/22

Search in Documents

Key Exhibits

External Links

Financials Filter

Prospectuses and Registrations Filter

Ownership Filter

News Filter

Proxies Filter

Other Filter

Imago BioSciences Inc Watch